Home › Immune System and Disorders › New York › Buffalo
Immune System and Disorders clinical trials in Buffalo, NY
3 studies for Immune System and Disorders are looking for participants at sites in and around Buffalo (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
RecruitingObservational study
- Roswell Park Cancer Institute, Buffalo
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RecruitingPhase 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RecruitingPhase 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
About Immune System and Disorders
Your immune system is made up of cells, tissues, and organs that fight infections and diseases. Learn how it works, and about diseases of the immune system.
More about Immune System and Disorders on MedlinePlus
Immune System and Disorders trials in other cities
- Washington, DC13 studies
- New York City, NY12 studies
- Boston, MA10 studies
- Portland, OR10 studies
- Atlanta, GA10 studies
- Philadelphia, PA10 studies
- Houston, TX9 studies
- Los Angeles, CA9 studies
- Cleveland, OH8 studies
- Chicago, IL8 studies
- Seattle, WA6 studies
- Milwaukee, WI6 studies
Other studies in Buffalo
- Acute Myeloid Leukemia20 studies
- Cancer (all types)18 studies
- Non-Small Cell Lung Cancer17 studies
- Breast Cancer17 studies
- Lung Cancer15 studies
- Ovarian Cancer14 studies
- Metastatic Cancer11 studies
- Melanoma10 studies
- Prostate Cancer10 studies
- Obesity10 studies
- Myelodysplastic Syndromes9 studies
- Multiple Myeloma9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.